Prof. Robert Loewe, MD, 
Dermatologist Vienna - Science

The treatment options for patients are always as good as the current state of medical knowledge and therefore subject to constant development. For this reason, I dedicate myself in addition to my clinical activity also passionately to dermatological research. As a researcher and scientist, I have been the head of my own research group at the Department of Dermatology of the Medical University of Vienna for many years, which primarily deals with basic research into skin cancer.

Personal achievments

  • basic and translational research
  • Discovery of the mechanism of action of dimethyl fumarate (the most commonly prescribed drug in Germany for the treatment of moderate and severe psoriasis). Prof. Loewe also holds a patent of this mechanism of action for further therapeutic use.
  • First description of the antitumor effect of dimethyl fumarate in human melanoma
  • Discovery of a new side effect of a systemic therapy of Parkinson's disease
  • Discovery of a new mutation in a family with inherited mastocytosis
  • Description of epidermal growth factor (EGF) as an important factor in the distribution of melanoma cells via the lymphatic system.
  • Detection of a melanoma-specific mutation (V600E) in growing birthmarks

Scientific cooperations

Department of Biology, Cell Biology and Physiology, University of Copenhagen

Centro Nacional de Investigaciones Oncológicas, CNIO (Spanish National Cancer Research Centre, Madrid)

Melanoma Research Center, The Wistar Institute, Philadelphia
Department of Pathology, Massachusetts General Hospital, Boston

I am a member of the Austrian Society of Dermatology and Venereology (ÖGDV), the Society of Investigative Dermatology (SID), the European Society of Dermatological Research (ESDR), the Arbeitsgemeinschaft Dermatologische Forschung (ADF) and the Austrian Society of Dermatopathology.

Since 2004, I have worked as a reviewer for national and international scientific journals and organizations, such as Nature Immunology, Cancer Research, Journal of Investigative Dermatology, Neoplasia, Journal of Experimental Clinical Cancer Research, European Journal of Pharmacology, Acta Dermato-Venereologica, Journal of the European Academy of Dermatology and Venerology, Archives of Dermatological Research, British Medical Journal, Acta dermatovenerologica, Histochemistry and Cell Biology, Wiener Klinische Wochenschrift, the Jubilee Fund of the Austrian National Bank, the Arbeitsgemeinschaft Dermatologische Forschung (ADF), the medical and scientific fund of the mayor of the federal capital of Vienna.

Clinical activities

  • Since 2008 establishment and management of the special clinic for rare skin tumors at the Department of Dermatology of the Medical University of Vienna / AKH Vienna
  • Founding member of the Vienna Center for Rare and Undiagnosed Diseases (CERUD) and member of the CERUD core team
  • Principal Investigator for Austria of Skilarence® (dimethylfumarate) pivotal study (Bridge Study) for the treatment of moderate and severe psoriasis
  • 2008 Foundation of the private ordination Dermatologist Prof Robert Loewe, MD Vienna at the Confraternity / Private Clinic Vienna Josefstadt, in 2018: Extension of the outpatient activities. Opening of a second location in 1180 Vienna.

 "At the center of medicine
stands the person with its well-being.

- Prof. Robert Loewe, MD, Dermatologist Vienna